Paolo Mattiello

Direct oral anticoagulants in patients with nonvalvular atrial fibrillation and extreme body weight

O. Alfieri, M. Filippi, A. Zangrillo, 2021, European journal of clinical investigation.

Inappropriate dose of nonvitamin-K antagonist oral anticoagulants: prevalence and impact on clinical outcome in patients with nonvalvular atrial fibrillation.

O. Alfieri, A. Zangrillo, M. Tresoldi, 2020, Journal of cardiovascular medicine.

Real-world 2-year outcome of atrial fibrillation treatment with dabigatran, apixaban, and rivaroxaban in patients with and without chronic kidney disease

A. Colombo, A. Margonato, P. Della Bella, 2019, Internal and Emergency Medicine.

Baseline Characteristics and 3-Year Outcome of Nonvalvular Atrial Fibrillation Patients Treated with the Four Direct Oral Anticoagulants (DOACs).

M. Tresoldi, A. Margonato, P. Della Bella, 2023, American Journal of Cardiology.